The septic milieu triggers expression of spliced tissue factor mRNA in human platelets

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 4, 2011, Pages 748-758

  Rondina, M T ^a   Schwertz, H ^a   Harris, E S ^a   Kraemer, B F ^a   Campbell, R A ^a   Mackman, N ^b   Grissom, C K ^a,c   Weyrich, A S ^a   Zimmerman, G A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Gene expression; Inflammation; Platelets; Post transcriptional pathways; Sepsis; Thrombosis

Indexed keywords

BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROCOAGULANT; STAPHYLOCOCCUS ALPHA TOXIN; THROMBOPLASTIN; TOXIN;

ADULT; APACHE; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM; BACTERIUM ISOLATION; BLOOD CLOT; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATION; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SPLICING; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; TISSUE FACTOR PRE MRNA SPLICING;

BASE SEQUENCE; BLOOD PLATELETS; DNA PRIMERS; HUMANS; RNA SPLICING; RNA, MESSENGER; SEPSIS;

EID: 79953305437     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04208.x     Document Type: Article

References (55)

1. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc 2003; 78: 869-81.
2. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, Marshall J, Nunn A, Opal S. New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001; 29: 880-6.
3. Levi M. Platelets at a crossroad of pathogenic pathways in sepsis. J Thromb Haemost 2004; 2: 2094-5.
4. Schwertz H, Weyrich AS, Zimmerman GA. Cellular interactions of platelets, leukocytes, and endothelium in systemic inflammatory responses and sepsis. In: Castro-Faria-Neto HC, David CM, eds. Sepsis: From Bench to Bedside. Rio de Janeiro: Revinter Press, 2007: 107-20.
5. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest 1999; 115: 1363-70.
6. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002; 30: 1765-71.
7. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28: 1871-6.
8. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002; 30: S313-7.
9. Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2003: 497-519.
10. Harris EH, Rondina MT, Schwertz H, Weyrich AS, Zimmerman GA. Pathogenesis of sepsis and sepsis-induced acute lung injury. In: Choi A, ed. Acute Respiratory Distress Syndrome, 2nd edn. New York: Informa Healthcare, 2010: 369-419.
11. Freedman JE. Molecular regulation of platelet-dependent thrombosis. Circulation 2005; 112: 2725-34.
12. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004; 25: 489-95.
13. Zimmerman GA, Weyrich AS. Signal-dependent protein synthesis by activated platelets: new pathways to altered phenotype and function. Arterioscler Thromb Vasc Biol 2008; 28: s17-24.
14. Weyrich AS, Denis MM, Schwertz H, Tolley ND, Foulks J, Spencer E, Kraiss LW, Albertine KH, Mcintyre TM, Zimmerman GA. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 2007; 109: 1975-83.
15. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, Yost CC, Rubner FJ, Albertine KH, Swoboda KJ, Fratto CM, Tolley E, Kraiss LW, Mcintyre TM, Zimmerman GA, Weyrich AS. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 2005; 122: 379-91.
16. Lindemann S, Mcintyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Platelet signal-dependent protein synthesis. In: Quinn M, Fitzgerald D, eds. Platelet Function: Assessment, Diagnosis, and Treatment. Totowa: The Humana Press, Inc., 2005: 151-76.
17. Lindemann S, Tolley ND, Dixon DA, Mcintyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154: 485-90.
18. Schwertz H, Tolley ND, Foulks JM, Denis MM, Risenmay BW, Buerke M, Tilley RE, Rondina MT, Harris EM, Kraiss LW, Mackman N, Zimmerman GA, Weyrich AS. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006; 203: 2433-40.
19. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007; 27: 1687-93.
20. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-91.
21. Gando S, Nanzaki S, Sasaki S, Kemmotsu O. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 1998; 79: 1111-5.
22. Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7: 23-38.
23. Pawlinski R, Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med 2004; 32: S293-7.
24. Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA. TAFI and PAI-1 levels in human sepsis. Thromb Res 2006; 118: 205-12.
25. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev 1991; 55: 733-51.
26. Munford RS. Severe sepsis and septic shock: the role of Gram-negative bacteremia. Annu Rev Pathol 2006; 1: 467-96.
27. Kawamoto T, Ii M, Kitazaki T, Iizawa Y, Kimura H. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. Eur J Pharmacol 2008; 584: 40-8.
28. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327.
29. Shashkin PN, Brown GT, Ghosh A, Marathe GK, Mcintyre TM. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol 2008; 181: 3495-502.
30. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6.
31. Bozza FA, Shah AM, Weyrich AS, Zimmerman GA. Amicus or adversary: platelets in lung biology, acute injury, and inflammation. Am J Respir Cell Mol Biol 2009; 40: 123-34.
32. Freishtat RJ, Natale J, Benton AS, Cohen J, Sharron M, Wiles AA, Ngor WM, Mojgani B, Bradbury M, Degnan A, Sachdeva R, Debiase LM, Ghimbovschi S, Chow M, Bunag C, Kristosturyan E, Hoffman EP. Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med 2009; 179: 467-73.
33. Meshorer E, Misteli T. Splicing misplaced. Cell 2005; 122: 317-8.
34. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol 2006; 26: 456-61.
35. Panes O, Matus V, Saez CG, Quiroga T, Pereira J, Mezzano D. Human platelets synthesize and express functional tissue factor. Blood 2007; 109: 5242-50.
36. Qian K, Xie F, Gibson AW, Edberg JC, Kimberly RP, Wu J. Functional expression of IgA receptor FcalphaRI on human platelets. J Leukoc Biol 2008; 84: 1492-500.
37. Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes 2010; 59: 1487-95.
38. Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2010; 67: 499-511.
39. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Pozzetto B, Mcnicol A, Garraud O. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 2008; 141: 84-91.
40. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006; 107: 637-41.
41. Clark SR, Ma AC, Tavener SA, Mcdonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, Mcavoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, Doig CJ, Green FH, Kubes P. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-9.
42. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009; 182: 7997-8004.
43. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 2005; 94: 831-8.
44. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
45. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis 2006; 36: 104-7.
46. Pawlinski R, Wang JG, Owens AP 3rd, Williams J, Antoniak S, Tencati M, Luther T, Rowley JW, Low EN, Weyrich AS, Mackman N. Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood 2010; 116: 806-14.
47. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731-8.
48. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost 1999; 81: 177-88.
49. Brambilla M, Camera M, Colnago D, Marenzi G, De Metrio M, Giesen PL, Balduini A, Veglia F, Gertow K, Biglioli P, Tremoli E. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol 2008; 28: 947-53.
50. Mezzano D, Matus V, Saez CG, Pereira J, Panes O. Tissue factor storage, synthesis and function in normal and activated human platelets. Thromb Res 2008; 122(Suppl 1): S31-6.
51. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby P, Ridker PM, Simon DI. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006; 113: 2278-84.
52. Raghavachari N, Xu X, Harris A, Villagra J, Logun C, Barb J, Solomon MA, Suffredini AF, Danner RL, Kato G, Munson PJ, Morris SM Jr, Gladwin MT. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease. Circulation 2007; 115: 1551-62.
53. Sun L, Gorospe JR, Hoffman EP, Rao AK. Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights from platelet expression profiling. J Thromb Haemost 2007; 5: 146-54.
54. Gnatenko DV, Zhu W, Xu X, Samuel ET, Monaghan M, Zarrabi MH, Kim C, Dhundale A, Bahou WF. Class prediction models of thrombocytosis using genetic biomarkers. Blood 2010; 115: 7-14.
55. Nagalla S, Bray PF. Platelet RNA chips dip into thrombocytosis. Blood 2010; 115: 2-3.